New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
about
Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: Attack of the Clones?Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant enterococci: Three major threats to hematopoietic stem cell transplant recipients.Antibiotic resistance in Staphylococcus aureus. Current status and future prospects.Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update.Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infectionsReview of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic.
P2860
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
@en
type
label
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
@en
prefLabel
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.
@en
P2093
P2860
P356
P1476
New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides
@en
P2093
David J Ritchie
Matthew P Crotty
Tamara Krekel
P2860
P304
P356
10.1128/JCM.03395-15
P407
P577
2016-03-09T00:00:00Z